| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | retinoic acid binding | 1.85e-06 | 28 | 64 | 4 | GO:0001972 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 2.22e-06 | 66 | 64 | 5 | GO:0005080 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 4.66e-06 | 35 | 64 | 4 | GO:0015020 | |
| GeneOntologyMolecularFunction | retinoid binding | 1.68e-05 | 48 | 64 | 4 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 1.82e-05 | 49 | 64 | 4 | GO:0019840 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 5.12e-05 | 303 | 64 | 7 | GO:0003713 | |
| GeneOntologyMolecularFunction | steroid binding | 6.76e-05 | 133 | 64 | 5 | GO:0005496 | |
| GeneOntologyMolecularFunction | fatty acid binding | 7.10e-05 | 69 | 64 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | alkaline phosphatase activity | 1.50e-04 | 6 | 64 | 2 | GO:0004035 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 3.87e-04 | 107 | 64 | 4 | GO:0033293 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 1.01e-03 | 239 | 64 | 5 | GO:0031406 | |
| GeneOntologyMolecularFunction | organic acid binding | 1.32e-03 | 254 | 64 | 5 | GO:0043177 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 1.47e-03 | 153 | 64 | 4 | GO:0008194 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 1.50e-03 | 18 | 64 | 2 | GO:0008381 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 2.09e-03 | 562 | 64 | 7 | GO:0003712 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 3.69e-10 | 5 | 62 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 1.10e-09 | 6 | 62 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 1.10e-09 | 6 | 62 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 1.10e-09 | 6 | 62 | 4 | GO:0051552 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 4.08e-09 | 21 | 62 | 5 | GO:0042447 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 1.53e-08 | 10 | 62 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 1.53e-08 | 10 | 62 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 5.18e-08 | 13 | 62 | 4 | GO:0009812 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 5.42e-08 | 34 | 62 | 5 | GO:0006706 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 2.58e-07 | 5 | 62 | 3 | GO:0052696 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 4.26e-07 | 21 | 62 | 4 | GO:0052695 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 1.05e-06 | 26 | 62 | 4 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 1.05e-06 | 26 | 62 | 4 | GO:0006063 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 5.58e-06 | 12 | 62 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 1.80e-05 | 52 | 62 | 4 | GO:0008210 | |
| GeneOntologyBiologicalProcess | liver development | 3.19e-05 | 202 | 62 | 6 | GO:0001889 | |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | 3.47e-05 | 205 | 62 | 6 | GO:0061008 | |
| GeneOntologyBiologicalProcess | gland development | 4.12e-05 | 558 | 62 | 9 | GO:0048732 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 4.92e-05 | 67 | 62 | 4 | GO:0019748 | |
| GeneOntologyBiologicalProcess | coenzyme A metabolic process | 5.00e-05 | 24 | 62 | 3 | GO:0015936 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 6.58e-05 | 141 | 62 | 5 | GO:0006805 | |
| GeneOntologyBiologicalProcess | lipid catabolic process | 1.45e-04 | 382 | 62 | 7 | GO:0016042 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | 1.69e-04 | 525 | 62 | 8 | GO:0009410 | |
| GeneOntologyBiologicalProcess | pigment metabolic process | 1.84e-04 | 94 | 62 | 4 | GO:0042440 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 1.84e-04 | 94 | 62 | 4 | GO:0016101 | |
| GeneOntologyBiologicalProcess | T cell antigen processing and presentation | 1.85e-04 | 7 | 62 | 2 | GO:0002457 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | 1.94e-04 | 684 | 62 | 9 | GO:0010817 | |
| GeneOntologyBiologicalProcess | skeletal muscle cell differentiation | 2.00e-04 | 96 | 62 | 4 | GO:0035914 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 2.16e-04 | 286 | 62 | 6 | GO:0042445 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 2.36e-04 | 40 | 62 | 3 | GO:0042573 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 2.82e-04 | 105 | 62 | 4 | GO:0006721 | |
| GeneOntologyBiologicalProcess | coenzyme A catabolic process | 3.16e-04 | 9 | 62 | 2 | GO:0015938 | |
| GeneOntologyBiologicalProcess | cellular response to lipid | 3.75e-04 | 748 | 62 | 9 | GO:0071396 | |
| GeneOntologyBiologicalProcess | response to lipid | HOXA13 NFKBIB SRD5A1 SMARCD1 IRS1 ATP1A1 KDM5D MN1 ADCY5 PCK1 TAT | 4.77e-04 | 1126 | 62 | 11 | GO:0033993 |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 5.43e-04 | 222 | 62 | 5 | GO:0071466 | |
| GeneOntologyBiologicalProcess | skeletal muscle tissue development | 5.54e-04 | 223 | 62 | 5 | GO:0007519 | |
| GeneOntologyBiologicalProcess | response to dexamethasone | 6.07e-04 | 55 | 62 | 3 | GO:0071548 | |
| GeneOntologyBiologicalProcess | myoblast differentiation | 7.50e-04 | 136 | 62 | 4 | GO:0045445 | |
| GeneOntologyBiologicalProcess | skeletal muscle organ development | 7.72e-04 | 240 | 62 | 5 | GO:0060538 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | 9.17e-04 | 376 | 62 | 6 | GO:0008202 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 9.28e-04 | 144 | 62 | 4 | GO:0006720 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | HK1 UGT1A10 UGT1A8 UGT1A7 GART UGT1A9 IRS1 SLC25A16 PCK1 TAT | 9.66e-04 | 1035 | 62 | 10 | GO:0019752 |
| GeneOntologyBiologicalProcess | response to ketone | 9.94e-04 | 254 | 62 | 5 | GO:1901654 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | HK1 UGT1A10 UGT1A8 UGT1A7 GART UGT1A9 IRS1 SLC25A16 PCK1 TAT | 1.14e-03 | 1058 | 62 | 10 | GO:0043436 |
| GeneOntologyBiologicalProcess | organic acid metabolic process | HK1 UGT1A10 UGT1A8 UGT1A7 GART UGT1A9 IRS1 SLC25A16 PCK1 TAT | 1.19e-03 | 1064 | 62 | 10 | GO:0006082 |
| GeneOntologyBiologicalProcess | nucleoside bisphosphate catabolic process | 1.47e-03 | 19 | 62 | 2 | GO:0033869 | |
| GeneOntologyBiologicalProcess | ribonucleoside bisphosphate catabolic process | 1.47e-03 | 19 | 62 | 2 | GO:0034031 | |
| GeneOntologyBiologicalProcess | purine nucleoside bisphosphate catabolic process | 1.47e-03 | 19 | 62 | 2 | GO:0034034 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | 1.49e-03 | 731 | 62 | 8 | GO:0032787 | |
| GeneOntologyCellularComponent | chromatin | HOXA13 PLK2 AHRR ARID1B ZFHX4 ETV3 SMARCD1 KLF17 TNKS1BP1 XPC PAX3 KDM5D RFX8 | 3.36e-04 | 1480 | 62 | 13 | GO:0000785 |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 6.61e-04 | 13 | 62 | 2 | GO:1990907 | |
| GeneOntologyCellularComponent | npBAF complex | 7.70e-04 | 14 | 62 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | brahma complex | 7.70e-04 | 14 | 62 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | nBAF complex | 1.01e-03 | 16 | 62 | 2 | GO:0071565 | |
| Domain | UDPGT | 7.18e-07 | 21 | 64 | 4 | PF00201 | |
| Domain | UDPGT | 7.18e-07 | 21 | 64 | 4 | PS00375 | |
| Domain | UDP_glucos_trans | 7.18e-07 | 21 | 64 | 4 | IPR002213 | |
| Domain | BCL9_beta-catenin-bd_dom | 1.16e-05 | 2 | 64 | 2 | IPR024670 | |
| Domain | BCL9 | 1.16e-05 | 2 | 64 | 2 | PF11502 | |
| Domain | Bcl-9 | 1.16e-05 | 2 | 64 | 2 | IPR015668 | |
| Domain | zf-RNPHF | 3.46e-05 | 3 | 64 | 2 | PF08080 | |
| Domain | Znf_CHHC | 3.46e-05 | 3 | 64 | 2 | IPR012996 | |
| Domain | Alk_phosphatase | 6.90e-05 | 4 | 64 | 2 | PF00245 | |
| Domain | Alkaline_phosphatase_AS | 6.90e-05 | 4 | 64 | 2 | IPR018299 | |
| Domain | Alkaline_phosphatase | 6.90e-05 | 4 | 64 | 2 | IPR001952 | |
| Domain | alkPPc | 6.90e-05 | 4 | 64 | 2 | SM00098 | |
| Domain | ALKALINE_PHOSPHATASE | 6.90e-05 | 4 | 64 | 2 | PS00123 | |
| Domain | Coact_PPARg | 6.90e-05 | 4 | 64 | 2 | IPR026784 | |
| Domain | Alkaline_phosphatase_core | 1.61e-04 | 31 | 64 | 3 | IPR017850 | |
| Domain | Alkaline_Pase-like_a/b/a | 1.61e-04 | 31 | 64 | 3 | IPR017849 | |
| Domain | - | 1.61e-04 | 31 | 64 | 3 | 3.40.720.10 | |
| Domain | TMC | 3.19e-04 | 8 | 64 | 2 | PF07810 | |
| Domain | TMC | 3.19e-04 | 8 | 64 | 2 | IPR012496 | |
| Domain | PIN_domain-like | 1.02e-03 | 14 | 64 | 2 | IPR029060 | |
| Domain | - | 1.18e-03 | 15 | 64 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 1.18e-03 | 15 | 64 | 2 | SM00501 | |
| Domain | ARID_dom | 1.18e-03 | 15 | 64 | 2 | IPR001606 | |
| Domain | ARID | 1.18e-03 | 15 | 64 | 2 | PS51011 | |
| Domain | ARID | 1.18e-03 | 15 | 64 | 2 | PF01388 | |
| Domain | ZnF_U1 | 4.42e-03 | 29 | 64 | 2 | SM00451 | |
| Domain | Znf_U1 | 4.42e-03 | 29 | 64 | 2 | IPR003604 | |
| Pathway | WP_GLUCURONIDATION | 2.82e-08 | 25 | 52 | 5 | MM15820 | |
| Pathway | WP_GLUCURONIDATION | 3.48e-08 | 26 | 52 | 5 | M39404 | |
| Pathway | WP_ESTROGEN_METABOLISM | 1.15e-06 | 22 | 52 | 4 | MM15888 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.28e-06 | 52 | 52 | 5 | M14171 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.66e-06 | 24 | 52 | 4 | MM14599 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 1.70e-06 | 55 | 52 | 5 | M14933 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.97e-06 | 25 | 52 | 4 | M17787 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 1.97e-06 | 25 | 52 | 4 | M605 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 3.16e-06 | 28 | 52 | 4 | M19580 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 1.06e-05 | 137 | 52 | 6 | M48232 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.23e-05 | 39 | 52 | 4 | MM15695 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 1.51e-05 | 41 | 52 | 4 | M7399 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 1.67e-05 | 14 | 52 | 3 | M39328 | |
| Pathway | REACTOME_ASPIRIN_ADME | 2.19e-05 | 45 | 52 | 4 | MM15694 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 3.62e-05 | 51 | 52 | 4 | M17726 | |
| Pathway | REACTOME_DRUG_ADME | 4.90e-05 | 109 | 52 | 5 | M45012 | |
| Pathway | KEGG_RETINOL_METABOLISM | 8.88e-05 | 64 | 52 | 4 | M9488 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 1.26e-04 | 70 | 52 | 4 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 1.41e-04 | 72 | 52 | 4 | M9257 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 1.62e-04 | 29 | 52 | 3 | M48076 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 2.85e-04 | 35 | 52 | 3 | M47969 | |
| Pathway | REACTOME_ASPIRIN_ADME | 5.64e-04 | 44 | 52 | 3 | M45014 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873 | 6.02e-04 | 45 | 52 | 3 | M39615 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 6.42e-04 | 107 | 52 | 4 | MM14595 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 6.88e-04 | 109 | 52 | 4 | M18788 | |
| Pathway | KEGG_FOLATE_BIOSYNTHESIS | 7.19e-04 | 11 | 52 | 2 | M2220 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 8.60e-04 | 12 | 52 | 2 | M39611 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_AND_POST_TRANSLATIONAL_REGULATION_OF_MITF_M_EXPRESSION_AND_ACTIVITY | 8.70e-04 | 51 | 52 | 3 | M48267 | |
| Pathway | REACTOME_DRUG_ADME | 9.56e-04 | 119 | 52 | 4 | MM15692 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 1.18e-03 | 14 | 52 | 2 | M46453 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.24e-03 | 219 | 52 | 5 | MM14838 | |
| Pathway | REACTOME_SPECIFICATION_OF_THE_NEURAL_PLATE_BORDER | 1.75e-03 | 17 | 52 | 2 | M48248 | |
| Pathway | KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY | 1.92e-03 | 67 | 52 | 3 | M10462 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN | 1.97e-03 | 18 | 52 | 2 | MM15336 | |
| Pathway | WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME | 1.98e-03 | 145 | 52 | 4 | M45512 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 2.41e-03 | 153 | 52 | 4 | MM15844 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN | 2.68e-03 | 21 | 52 | 2 | M27634 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 2.68e-03 | 21 | 52 | 2 | M39631 | |
| Pathway | REACTOME_DIGESTION | 2.68e-03 | 21 | 52 | 2 | MM15526 | |
| Pubmed | 1.56e-10 | 6 | 64 | 4 | 32527940 | ||
| Pubmed | 1.56e-10 | 6 | 64 | 4 | 20297805 | ||
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 3.63e-10 | 7 | 64 | 4 | 8467709 | |
| Pubmed | 3.63e-10 | 7 | 64 | 4 | 8464825 | ||
| Pubmed | 3.63e-10 | 7 | 64 | 4 | 27514509 | ||
| Pubmed | 7.26e-10 | 8 | 64 | 4 | 17179145 | ||
| Pubmed | 7.26e-10 | 8 | 64 | 4 | 20610558 | ||
| Pubmed | 7.26e-10 | 8 | 64 | 4 | 18052087 | ||
| Pubmed | 1.30e-09 | 9 | 64 | 4 | 22511988 | ||
| Pubmed | 2.17e-09 | 10 | 64 | 4 | 23642732 | ||
| Pubmed | 2.17e-09 | 10 | 64 | 4 | 11465080 | ||
| Pubmed | 2.17e-09 | 10 | 64 | 4 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 2.17e-09 | 10 | 64 | 4 | 22558097 | |
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 5.10e-09 | 12 | 64 | 4 | 20308471 | |
| Pubmed | 5.10e-09 | 12 | 64 | 4 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 5.10e-09 | 12 | 64 | 4 | 11434514 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 29519853 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 12847094 | ||
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 7.36e-09 | 13 | 64 | 4 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 7.36e-09 | 13 | 64 | 4 | 25246029 | |
| Pubmed | 1.03e-08 | 14 | 64 | 4 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 1.03e-08 | 14 | 64 | 4 | 10836148 | |
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 1.03e-08 | 14 | 64 | 4 | 14672974 | |
| Pubmed | 1.03e-08 | 14 | 64 | 4 | 9295054 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 1.87e-08 | 16 | 64 | 4 | 19414484 | |
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 17558305 | ||
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 2.44e-08 | 17 | 64 | 4 | 20639394 | |
| Pubmed | 3.13e-08 | 18 | 64 | 4 | 20056724 | ||
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 3.96e-08 | 19 | 64 | 4 | 23281178 | |
| Pubmed | 5.93e-08 | 5 | 64 | 3 | 20565459 | ||
| Pubmed | 5.93e-08 | 5 | 64 | 3 | 15057901 | ||
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 1.08e-07 | 24 | 64 | 4 | 24625756 | |
| Pubmed | 2.07e-07 | 7 | 64 | 3 | 30366904 | ||
| Pubmed | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. | 4.95e-07 | 9 | 64 | 3 | 20732626 | |
| Pubmed | 9.70e-07 | 11 | 64 | 3 | 18695635 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 25547628 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 38811552 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 15371335 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 11901093 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 11677206 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 22031623 | ||
| Pubmed | Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10. | 3.33e-06 | 2 | 64 | 2 | 10497143 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 18568343 | ||
| Pubmed | Human UGT1A8 and UGT1A10 mRNA are expressed in primary human hepatocytes. | 3.33e-06 | 2 | 64 | 2 | 17603215 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 15709193 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 12944498 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 20682801 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 33767438 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 9647757 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 17529886 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 20089735 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 3.81e-06 | 351 | 64 | 7 | 38297188 | |
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 3.83e-06 | 57 | 64 | 4 | 21886157 | |
| Pubmed | Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription. | 4.40e-06 | 59 | 64 | 4 | 28813667 | |
| Pubmed | 5.03e-06 | 61 | 64 | 4 | 20305087 | ||
| Pubmed | 6.90e-06 | 66 | 64 | 4 | 19898482 | ||
| Pubmed | Interaction of antiproliferative protein Tob with the CCR4-NOT deadenylase complex. | 8.93e-06 | 22 | 64 | 3 | 18377426 | |
| Pubmed | Two gene duplication events in the evolution of the human heat-stable alkaline phosphatases. | 9.99e-06 | 3 | 64 | 2 | 3443302 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 19364970 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 34545187 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 16636344 | ||
| Pubmed | Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. | 9.99e-06 | 3 | 64 | 2 | 20007669 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 23721685 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 33649334 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 19244109 | ||
| Pubmed | Pax3 synergizes with Gli2 and Zic1 in transactivating the Myf5 epaxial somite enhancer. | 9.99e-06 | 3 | 64 | 2 | 24036067 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 26247833 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 19407215 | ||
| Pubmed | Genomic structure and comparison of mouse tissue-specific alkaline phosphatase genes. | 9.99e-06 | 3 | 64 | 2 | 2286375 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 17339869 | ||
| Pubmed | Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations. | 9.99e-06 | 3 | 64 | 2 | 24453052 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 19225446 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 23789755 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 10456323 | ||
| Pubmed | Intestinal Alkaline Phosphatase Regulates Tight Junction Protein Levels. | 9.99e-06 | 3 | 64 | 2 | 27106638 | |
| Pubmed | Organic pyrophosphates as substrates for human alkaline phosphatases. | 9.99e-06 | 3 | 64 | 2 | 16742561 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 17406868 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 10767088 | ||
| Pubmed | MUSEAP, a novel reporter gene for the study of long-term gene expression in immunocompetent mice. | 9.99e-06 | 3 | 64 | 2 | 11722850 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 19996319 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 14980514 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 16397224 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 17901166 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 21068389 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 20637214 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 7499401 | ||
| Pubmed | BCL9L KMT2C ARID1B FAM120A AGO3 ZFHX4 NFKBIB ZNF638 ETV3 SMARCD1 ATP1A1 BCL9 | 1.00e-05 | 1429 | 64 | 12 | 35140242 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.18e-05 | 774 | 64 | 9 | 15302935 | |
| Pubmed | 1.69e-05 | 615 | 64 | 8 | 31048545 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 21900644 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 18946804 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 20147615 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 39273477 | ||
| Pubmed | Structural evidence of functional divergence in human alkaline phosphatases. | 2.00e-05 | 4 | 64 | 2 | 12372831 | |
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 14585507 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 19699733 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 20628391 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 9061447 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 9271343 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 23700788 | ||
| Interaction | FOXI1 interactions | 4.65e-07 | 92 | 64 | 6 | int:FOXI1 | |
| Interaction | TBR1 interactions | 1.56e-06 | 113 | 64 | 6 | int:TBR1 | |
| Interaction | PAX9 interactions | 3.54e-06 | 130 | 64 | 6 | int:PAX9 | |
| Interaction | GSC interactions | 8.33e-06 | 87 | 64 | 5 | int:GSC | |
| Interaction | UGT1A9 interactions | 8.54e-06 | 13 | 64 | 3 | int:UGT1A9 | |
| Interaction | SOX17 interactions | 1.28e-05 | 95 | 64 | 5 | int:SOX17 | |
| Interaction | LHX4 interactions | 1.44e-05 | 166 | 64 | 6 | int:LHX4 | |
| Interaction | CRX interactions | 1.57e-05 | 254 | 64 | 7 | int:CRX | |
| Interaction | WWP1 interactions | 1.82e-05 | 260 | 64 | 7 | int:WWP1 | |
| Interaction | LHX1 interactions | 1.90e-05 | 103 | 64 | 5 | int:LHX1 | |
| Interaction | ART5 interactions | 2.07e-05 | 51 | 64 | 4 | int:ART5 | |
| Interaction | LHX2 interactions | 2.50e-05 | 183 | 64 | 6 | int:LHX2 | |
| Interaction | PAX8 interactions | 2.73e-05 | 111 | 64 | 5 | int:PAX8 | |
| Interaction | UGT1A8 interactions | 2.97e-05 | 3 | 64 | 2 | int:UGT1A8 | |
| Interaction | UGT1A7 interactions | 3.22e-05 | 57 | 64 | 4 | int:UGT1A7 | |
| Interaction | TBXT interactions | 3.37e-05 | 116 | 64 | 5 | int:TBXT | |
| Interaction | GATA2 interactions | 4.00e-05 | 199 | 64 | 6 | int:GATA2 | |
| Interaction | PAX7 interactions | 4.64e-05 | 124 | 64 | 5 | int:PAX7 | |
| Interaction | SP7 interactions | 4.94e-05 | 304 | 64 | 7 | int:SP7 | |
| Interaction | GCM1 interactions | 6.47e-05 | 68 | 64 | 4 | int:GCM1 | |
| Interaction | ERG interactions | 7.53e-05 | 223 | 64 | 6 | int:ERG | |
| Interaction | NFIX interactions | 8.31e-05 | 227 | 64 | 6 | int:NFIX | |
| Interaction | NFIB interactions | 8.83e-05 | 142 | 64 | 5 | int:NFIB | |
| Interaction | PAX2 interactions | 1.54e-04 | 85 | 64 | 4 | int:PAX2 | |
| Interaction | UGT1A10 interactions | 1.56e-04 | 33 | 64 | 3 | int:UGT1A10 | |
| Interaction | ESRRB interactions | 1.82e-04 | 262 | 64 | 6 | int:ESRRB | |
| Interaction | SOX10 interactions | 2.10e-04 | 92 | 64 | 4 | int:SOX10 | |
| Interaction | EGR2 interactions | 2.11e-04 | 171 | 64 | 5 | int:EGR2 | |
| Interaction | TLX1 interactions | 2.35e-04 | 175 | 64 | 5 | int:TLX1 | |
| Interaction | SOX9 interactions | 2.57e-04 | 97 | 64 | 4 | int:SOX9 | |
| Interaction | LHX3 interactions | 3.04e-04 | 185 | 64 | 5 | int:LHX3 | |
| Interaction | TLX3 interactions | 3.20e-04 | 291 | 64 | 6 | int:TLX3 | |
| Cytoband | 2q37 | 7.42e-10 | 31 | 64 | 5 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 7.87e-07 | 226 | 64 | 6 | chr2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p34 | 7.74e-04 | 294 | 64 | 4 | chr1p34 | |
| Cytoband | 1p34 | 9.24e-04 | 32 | 64 | 2 | 1p34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5p15 | 2.95e-03 | 204 | 64 | 3 | chr5p15 | |
| GeneFamily | UDP glucuronosyltransferases | 5.72e-07 | 32 | 38 | 4 | 363 | |
| GeneFamily | Alkaline phosphatases | 2.57e-05 | 4 | 38 | 2 | 1072 | |
| GeneFamily | Transmembrane channel likes | 1.19e-04 | 8 | 38 | 2 | 1135 | |
| GeneFamily | AT-rich interaction domain containing | 4.44e-04 | 15 | 38 | 2 | 418 | |
| GeneFamily | RNA binding motif containing | 1.00e-02 | 213 | 38 | 3 | 725 | |
| GeneFamily | PHD finger proteins | 1.53e-02 | 90 | 38 | 2 | 88 | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial-Uncommitted_AE_Progenitor|E18.5-samps / Age Group, Lineage, Cell class and subclass | 9.43e-07 | 123 | 64 | 5 | 5f002f5180fe47fe57ab888b5f0319df99ab2c59 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 4.76e-06 | 171 | 64 | 5 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 | |
| Drug | naringenin chalcone | 2.83e-10 | 5 | 64 | 4 | ctd:C027329 | |
| Drug | anthrarobin | 2.83e-10 | 5 | 64 | 4 | ctd:C032186 | |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 8.48e-10 | 6 | 64 | 4 | ctd:C543211 | |
| Drug | alloin | 8.48e-10 | 6 | 64 | 4 | ctd:C006457 | |
| Drug | 2',5'-dihydroxychalcone | 8.48e-10 | 6 | 64 | 4 | ctd:C107497 | |
| Drug | 6-hydroxychrysene | 9.02e-10 | 17 | 64 | 5 | CID000037766 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 1.25e-09 | 18 | 64 | 5 | CID000036614 | |
| Drug | 2',4'-dihydroxychalcone | 1.97e-09 | 7 | 64 | 4 | ctd:C059354 | |
| Drug | entacapone | 2.25e-09 | 20 | 64 | 5 | ctd:C071192 | |
| Drug | plumbagin | 3.80e-09 | 22 | 64 | 5 | ctd:C014758 | |
| Drug | 1,4-dihydroxyanthraquinone | 3.94e-09 | 8 | 64 | 4 | ctd:C034890 | |
| Drug | AC1MRQNQ | 7.08e-09 | 9 | 64 | 4 | CID003522271 | |
| Drug | DHPASiU | 7.08e-09 | 9 | 64 | 4 | CID000197602 | |
| Drug | Chebi:32663 | 7.08e-09 | 9 | 64 | 4 | CID005460873 | |
| Drug | 3-iodophenol | 7.08e-09 | 9 | 64 | 4 | CID000012272 | |
| Drug | AC1L4J7U | 7.08e-09 | 9 | 64 | 4 | CID000186631 | |
| Drug | Hymecromone | 7.61e-09 | 25 | 64 | 5 | ctd:D006923 | |
| Drug | Scopoletin | 1.15e-08 | 27 | 64 | 5 | ctd:D012603 | |
| Drug | 2,6-dihydroxyanthraquinone | 1.18e-08 | 10 | 64 | 4 | ctd:C034889 | |
| Drug | 4-nitrophenyl)imidazole | 1.85e-08 | 11 | 64 | 4 | CID000123155 | |
| Drug | AC1O5XMV | 1.85e-08 | 11 | 64 | 4 | CID006442661 | |
| Drug | paricalcitol | 2.02e-08 | 30 | 64 | 5 | CID005281104 | |
| Drug | PCB 156 | 2.40e-08 | 31 | 64 | 5 | CID000038019 | |
| Drug | N-OH-DABZ | 2.76e-08 | 12 | 64 | 4 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 2.76e-08 | 12 | 64 | 4 | CID000088735 | |
| Drug | 4-hydroxyestrone | 2.76e-08 | 12 | 64 | 4 | ctd:C026418 | |
| Drug | 2,4,6-TCB | 2.76e-08 | 12 | 64 | 4 | CID000037247 | |
| Drug | 7,7,7-triphenylheptanoic acid | 2.76e-08 | 12 | 64 | 4 | CID000276709 | |
| Drug | nonanoyl-N-methylglucamide | 2.76e-08 | 12 | 64 | 4 | CID000160090 | |
| Drug | AC1MRGT8 | 3.39e-08 | 67 | 64 | 6 | CID003517815 | |
| Drug | pregnenolone-16 alpha-carbonitrile | 3.39e-08 | 67 | 64 | 6 | CID000015032 | |
| Drug | 2-hydroxyestrone | 3.98e-08 | 13 | 64 | 4 | ctd:C024980 | |
| Drug | tritanol | 3.98e-08 | 13 | 64 | 4 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 3.98e-08 | 13 | 64 | 4 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 3.98e-08 | 13 | 64 | 4 | CID000000411 | |
| Drug | alizarin | 3.98e-08 | 13 | 64 | 4 | ctd:C010078 | |
| Drug | AC1L4B0X | 5.14e-08 | 122 | 64 | 7 | CID000153769 | |
| Drug | propranolol glucuronide | 5.56e-08 | 14 | 64 | 4 | CID000119515 | |
| Drug | PCB-61 | 5.56e-08 | 14 | 64 | 4 | CID000036401 | |
| Drug | x Me | 6.99e-08 | 38 | 64 | 5 | CID009600424 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 7.57e-08 | 15 | 64 | 4 | CID000040469 | |
| Drug | coumarin-3-carboxylic acid | 7.57e-08 | 15 | 64 | 4 | CID000010752 | |
| Drug | bergamottin | 7.57e-08 | 15 | 64 | 4 | ctd:C068337 | |
| Drug | sulforaphane nitrile | 7.57e-08 | 15 | 64 | 4 | CID000543743 | |
| Drug | afloqualone | 7.57e-08 | 15 | 64 | 4 | CID000002040 | |
| Drug | naphthyl sulphate | 7.57e-08 | 15 | 64 | 4 | CID000114775 | |
| Drug | 1-phenylimidazole | 8.00e-08 | 39 | 64 | 5 | CID000081595 | |
| Drug | 2-vanillin | 8.46e-08 | 4 | 64 | 3 | ctd:C060843 | |
| Drug | hydratropic acid | 8.46e-08 | 4 | 64 | 3 | ctd:C013025 | |
| Drug | diphenylacetic acid | 8.46e-08 | 4 | 64 | 3 | ctd:C037760 | |
| Drug | quercetin-3,4'-diglucoside | 1.01e-07 | 16 | 64 | 4 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 1.01e-07 | 16 | 64 | 4 | CID000040003 | |
| Drug | bilirubin-phosphate | 1.01e-07 | 16 | 64 | 4 | CID005497144 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 1.31e-07 | 17 | 64 | 4 | CID000003573 | |
| Drug | anthraflavic acid | 1.49e-07 | 44 | 64 | 5 | CID000006776 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 1.69e-07 | 18 | 64 | 4 | CID000152226 | |
| Drug | Br 2 | 1.69e-07 | 18 | 64 | 4 | CID003060900 | |
| Drug | SureCN12722713 | 1.69e-07 | 18 | 64 | 4 | CID005488034 | |
| Drug | ApApG | 1.69e-07 | 18 | 64 | 4 | CID003081975 | |
| Drug | C1 11-32 | 1.69e-07 | 18 | 64 | 4 | CID000443077 | |
| Drug | C11131 | 1.69e-07 | 18 | 64 | 4 | CID000443076 | |
| Drug | isovaleric acid | 2.11e-07 | 5 | 64 | 3 | ctd:C008216 | |
| Drug | biphenylylacetic acid | 2.11e-07 | 5 | 64 | 3 | ctd:C012776 | |
| Drug | almokalant | 2.13e-07 | 19 | 64 | 4 | CID003033962 | |
| Drug | 9-OH-risperidone | 2.13e-07 | 19 | 64 | 4 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 2.13e-07 | 19 | 64 | 4 | CID000091433 | |
| Drug | tectochrysin | 2.66e-07 | 20 | 64 | 4 | CID005281954 | |
| Drug | AC1L1OBF | 2.66e-07 | 20 | 64 | 4 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 2.66e-07 | 20 | 64 | 4 | CID000116545 | |
| Drug | Finrazole | 3.18e-07 | 51 | 64 | 5 | CID000178036 | |
| Drug | estriol-16-glucuronide | 3.28e-07 | 21 | 64 | 4 | CID000122281 | |
| Drug | dulcin | 3.28e-07 | 21 | 64 | 4 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 3.28e-07 | 21 | 64 | 4 | CID000069186 | |
| Drug | amonafide | 4.00e-07 | 22 | 64 | 4 | CID000050515 | |
| Drug | N-methylpiperazine | 4.00e-07 | 22 | 64 | 4 | CID000053167 | |
| Drug | 3-phenylpropionic acid | 4.21e-07 | 6 | 64 | 3 | ctd:C035253 | |
| Drug | Indoprofen | 4.21e-07 | 6 | 64 | 3 | ctd:D007216 | |
| Drug | Equol | 4.26e-07 | 54 | 64 | 5 | ctd:D060754 | |
| Drug | amidoxime | 4.83e-07 | 23 | 64 | 4 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 4.83e-07 | 23 | 64 | 4 | CID000066651 | |
| Drug | phenanthridine | 4.83e-07 | 23 | 64 | 4 | CID000009189 | |
| Drug | AS-3201 | 5.78e-07 | 24 | 64 | 4 | CID000153948 | |
| Drug | 4-nitrophenol | 6.52e-07 | 177 | 64 | 7 | CID000000980 | |
| Drug | 2-naphthylamine | 6.62e-07 | 110 | 64 | 6 | CID000007057 | |
| Drug | urochloralic acid | 6.67e-07 | 59 | 64 | 5 | CID003036914 | |
| Drug | 5-MOP | 6.87e-07 | 25 | 64 | 4 | CID000002355 | |
| Drug | AzMC | 6.87e-07 | 25 | 64 | 4 | CID000064986 | |
| Drug | N-acetylbenzidine | 6.87e-07 | 25 | 64 | 4 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 6.87e-07 | 25 | 64 | 4 | CID000006796 | |
| Drug | N-phenylmaleimide | 6.87e-07 | 25 | 64 | 4 | CID000013662 | |
| Drug | Thymol | 8.10e-07 | 26 | 64 | 4 | ctd:D013943 | |
| Drug | 3-OHBaP | 9.28e-07 | 63 | 64 | 5 | CID000025890 | |
| Drug | DiMeIQx | 9.49e-07 | 27 | 64 | 4 | CID000104739 | |
| Drug | licochalcone A | 9.49e-07 | 27 | 64 | 4 | ctd:C070840 | |
| Drug | diflunisal | 9.49e-07 | 27 | 64 | 4 | CID000003059 | |
| Drug | benzphetamine | 1.05e-06 | 119 | 64 | 6 | CID000002341 | |
| Drug | N-hydroxy-4-aminobiphenyl | 1.10e-06 | 28 | 64 | 4 | CID000081261 | |
| Drug | CARMINE | 1.10e-06 | 28 | 64 | 4 | CID000014749 | |
| Drug | erucin | 1.10e-06 | 28 | 64 | 4 | CID000078160 | |
| Drug | H-Ni | 1.10e-06 | 28 | 64 | 4 | CID000445665 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 1.00e-10 | 5 | 64 | 4 | EFO_0801060 | |
| Disease | 5-hydroxyindole sulfate measurement | 1.00e-10 | 5 | 64 | 4 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 1.00e-10 | 5 | 64 | 4 | EFO_0801853 | |
| Disease | X-21339 measurement | 7.01e-10 | 7 | 64 | 4 | EFO_0800808 | |
| Disease | X-11793--oxidized bilirubin measurement | 1.40e-09 | 8 | 64 | 4 | EFO_0021260 | |
| Disease | Succinimide measurement | 1.40e-09 | 8 | 64 | 4 | EFO_0022118 | |
| Disease | X-11530 measurement | 1.40e-09 | 8 | 64 | 4 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 1.40e-09 | 8 | 64 | 4 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 1.40e-09 | 8 | 64 | 4 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 1.40e-09 | 8 | 64 | 4 | EFO_0800696 | |
| Disease | X-10458 measurement | 1.40e-09 | 8 | 64 | 4 | EFO_0800692 | |
| Disease | X-24849 measurement | 1.40e-09 | 8 | 64 | 4 | EFO_0800909 | |
| Disease | serum N-desmethylclozapine measurement | 1.40e-09 | 8 | 64 | 4 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 1.40e-09 | 8 | 64 | 4 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 1.40e-09 | 8 | 64 | 4 | EFO_0802740 | |
| Disease | X-16946 measurement | 1.40e-09 | 8 | 64 | 4 | EFO_0800766 | |
| Disease | X-11442 measurement | 2.51e-09 | 9 | 64 | 4 | EFO_0021236 | |
| Disease | X-11441 measurement | 2.51e-09 | 9 | 64 | 4 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 2.51e-09 | 9 | 64 | 4 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 2.51e-09 | 9 | 64 | 4 | EFO_0801037 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 2.51e-09 | 9 | 64 | 4 | EFO_0802127 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 2.51e-09 | 9 | 64 | 4 | EFO_0801036 | |
| Disease | X-11880 measurement | 2.51e-09 | 9 | 64 | 4 | EFO_0800698 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 2.51e-09 | 9 | 64 | 4 | EFO_0004570, GO_0009410 | |
| Disease | protein-tyrosine kinase 6 measurement | 2.51e-09 | 9 | 64 | 4 | EFO_0020691 | |
| Disease | X-21448 measurement | 4.18e-09 | 10 | 64 | 4 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 4.18e-09 | 10 | 64 | 4 | EFO_0802185 | |
| Disease | X-23974 measurement | 4.18e-09 | 10 | 64 | 4 | EFO_0800867 | |
| Disease | bilirubin measurement, response to tenofovir | 4.18e-09 | 10 | 64 | 4 | EFO_0004570, EFO_0009279 | |
| Disease | X-21796 measurement | 6.56e-09 | 11 | 64 | 4 | EFO_0800825 | |
| Disease | pregnenetriol sulfate measurement | 6.56e-09 | 11 | 64 | 4 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 6.56e-09 | 11 | 64 | 4 | EFO_0600039 | |
| Disease | insomnia, bilirubin measurement | 6.56e-09 | 11 | 64 | 4 | EFO_0004570, EFO_0004698 | |
| Disease | histidine betaine (hercynine) measurement | 6.56e-09 | 11 | 64 | 4 | EFO_0800972 | |
| Disease | aldosterone measurement | 6.56e-09 | 11 | 64 | 4 | EFO_0010219 | |
| Disease | blood 4-oxo-retinoic acid measurement | 9.73e-09 | 3 | 64 | 3 | EFO_0022216 | |
| Disease | indole-3-carboxylate measurement | 9.73e-09 | 3 | 64 | 3 | EFO_0800043 | |
| Disease | biliverdin measurement | 9.83e-09 | 12 | 64 | 4 | EFO_0021033 | |
| Disease | p-cresol glucuronide measurement | 9.83e-09 | 12 | 64 | 4 | EFO_0800079 | |
| Disease | retinol dehydrogenase 16 measurement | 1.42e-08 | 13 | 64 | 4 | EFO_0802007 | |
| Disease | pregnenetriol disulfate measurement | 1.42e-08 | 13 | 64 | 4 | EFO_0800587 | |
| Disease | X-21441 measurement | 4.69e-08 | 17 | 64 | 4 | EFO_0800814 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 4.69e-08 | 17 | 64 | 4 | EFO_0004611, EFO_0007800 | |
| Disease | angiopoietin-related protein 1 measurement | 6.02e-08 | 18 | 64 | 4 | EFO_0801382 | |
| Disease | tissue factor measurement | 1.17e-07 | 21 | 64 | 4 | EFO_0010623 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 1.94e-07 | 6 | 64 | 3 | EFO_0800566 | |
| Disease | neuroblastoma, cutaneous melanoma | 3.96e-07 | 28 | 64 | 4 | EFO_0000389, EFO_0000621 | |
| Disease | xanthurenate measurement | 4.59e-07 | 29 | 64 | 4 | EFO_0010551 | |
| Disease | response to dolutegravir | 5.29e-07 | 30 | 64 | 4 | EFO_0600017 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 8.15e-07 | 147 | 64 | 6 | DOID:9352 (biomarker_via_orthology) | |
| Disease | indoleacetate measurement | 1.16e-06 | 10 | 64 | 3 | EFO_0021015 | |
| Disease | vitamin D deficiency | 1.26e-06 | 37 | 64 | 4 | EFO_0003762 | |
| Disease | X-24588 measurement | 2.74e-06 | 13 | 64 | 3 | EFO_0800898 | |
| Disease | vitamin D measurement, COVID-19 | 3.96e-06 | 49 | 64 | 4 | EFO_0004631, MONDO_0100096 | |
| Disease | urate measurement, spine bone mineral density | 7.82e-06 | 58 | 64 | 4 | EFO_0004531, EFO_0007701 | |
| Disease | thyroxine measurement | 3.25e-05 | 83 | 64 | 4 | EFO_0005130 | |
| Disease | hormone measurement | 3.41e-05 | 84 | 64 | 4 | EFO_0004730 | |
| Disease | cholelithiasis | 4.09e-05 | 88 | 64 | 4 | EFO_0004799 | |
| Disease | Neurodevelopmental Disorders | 5.08e-05 | 93 | 64 | 4 | C1535926 | |
| Disease | vitamin D measurement | 8.97e-05 | 336 | 64 | 6 | EFO_0004631 | |
| Disease | gallstones | 9.11e-05 | 108 | 64 | 4 | EFO_0004210 | |
| Disease | Major Depressive Disorder | 1.87e-04 | 243 | 64 | 5 | C1269683 | |
| Disease | Global developmental delay | 2.03e-04 | 133 | 64 | 4 | C0557874 | |
| Disease | metabolite measurement | 2.08e-04 | 560 | 64 | 7 | EFO_0004725 | |
| Disease | Unipolar Depression | 2.51e-04 | 259 | 64 | 5 | C0041696 | |
| Disease | dodecanedioate measurement | 3.01e-04 | 12 | 64 | 2 | EFO_0021054 | |
| Disease | Intellectual Disability | 4.17e-04 | 447 | 64 | 6 | C3714756 | |
| Disease | Feeding difficulties | 6.93e-04 | 18 | 64 | 2 | C0232466 | |
| Disease | Craniosynostosis | 8.58e-04 | 20 | 64 | 2 | C0010278 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 8.62e-04 | 195 | 64 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of lung (disorder) | 1.06e-03 | 206 | 64 | 4 | C0152013 | |
| Disease | free androgen index | 1.32e-03 | 374 | 64 | 5 | EFO_0007005 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 1.69e-03 | 28 | 64 | 2 | DOID:4194 (implicated_via_orthology) | |
| Disease | Streptozotocin Diabetes | 1.69e-03 | 108 | 64 | 3 | C0038433 | |
| Disease | Diabetes Mellitus, Experimental | 1.69e-03 | 108 | 64 | 3 | C0011853 | |
| Disease | Alloxan Diabetes | 1.69e-03 | 108 | 64 | 3 | C0002152 | |
| Disease | monocyte count | 2.10e-03 | 1320 | 64 | 9 | EFO_0005091 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MPRTMIPPGECTYAG | 1 | A9YTQ3 | |
| YDLLFMPPSFPFGGM | 286 | Q9H4A4 | |
| PIKPGMFGYGRVPFA | 151 | Q6UY14 | |
| LMKPLFPGMGFIFRN | 386 | Q9C073 | |
| KPDIMLPLFARPGMY | 226 | P41162 | |
| GRMPYEPNKDPFGGM | 1341 | Q8NFD5 | |
| MVPRRPGYGTMGKPI | 16 | Q9H9G7 | |
| KGEMMTYFLNGGPPL | 1246 | O95622 | |
| MFARKPPGAAPLGAM | 1 | Q9UQB3 | |
| GLMPTILGMAPYAGV | 191 | P16260 | |
| GRTMYVIPFSMGPLG | 136 | P35558 | |
| DQRGPYPPDVASMGM | 2461 | Q8NEZ4 | |
| PGLRPVRPSGAMYLM | 361 | P17735 | |
| LKMGYHFELPGPRMV | 371 | Q0VAK6 | |
| CPGMGVALRMYPLKP | 971 | P05023 | |
| LQIYGPGPKMMGLGL | 236 | Q9BY66 | |
| MYGGRTPLGSAMLRP | 271 | Q15653 | |
| LMAMQRPGPYDRPGA | 201 | P55795 | |
| PYGYRGIGGMKPSMS | 2981 | Q9Y6V0 | |
| GGPRESSYMEMKGPP | 936 | Q5VY43 | |
| LLTGRLPVRMGMYPG | 76 | P15289 | |
| LPVRMGMYPGVLVPS | 81 | P15289 | |
| HYLAARPGPFGMPGM | 341 | Q9NZB2 | |
| LMAMQRPGPYDRPGA | 201 | P31943 | |
| PVPSGRKGSGDYMPM | 621 | P35568 | |
| LDYMGIKGPRMPLGF | 586 | P19367 | |
| GAVPRMMRPGPGQNY | 6 | P23760 | |
| MMRPGPGQNYPRSGF | 11 | P23760 | |
| DVILGGGRKYMFPMG | 216 | P09923 | |
| GGRKYMFPMGTPDPE | 221 | P09923 | |
| DVILGGGRKYMFPMG | 216 | P10696 | |
| GGRKYMFPMGTPDPE | 221 | P10696 | |
| LRGAVMIVYPMGLPP | 146 | P57076 | |
| MPRYAQLVMGPAGSG | 1 | Q9UHW5 | |
| EYGMGPRPFLPMSQG | 776 | O00512 | |
| MGSMPLPPQGRSRGF | 931 | Q9NX05 | |
| TMPYPGGQGEAERFM | 656 | Q86UU0 | |
| GPQFSMPLPERGMSY | 86 | Q5JT82 | |
| MFYIGAHRGLMPPLP | 1276 | Q56UN5 | |
| GEPPILGMNMEPYGF | 56 | Q10571 | |
| FRGPLQEPMRMPGEG | 676 | Q10571 | |
| YHMKPLRMARPGGPE | 3121 | Q5T011 | |
| AAYPRPGMLPGSRMT | 56 | Q96GM5 | |
| AGMPYLGQAPFLGMR | 91 | Q9UMZ2 | |
| MPGYLDMPVVPGLGG | 246 | P31271 | |
| MPMYQVKPYHGGGAP | 1 | Q13155 | |
| PPGNRKMHGDLMYLF | 226 | O75153 | |
| PSEFGGMLPPYDMGT | 246 | Q5SYC1 | |
| IGMPSLMYRSPPGAE | 351 | Q86VR2 | |
| VCGMESLFPYGPTMP | 3241 | Q86UP3 | |
| GSGTPVRGLPYAMMD | 31 | Q8IU68 | |
| MEAEPPLYPMAGAAG | 1 | Q9H1C4 | |
| YPKPVMPNMIFIGGI | 261 | Q9HAW8 | |
| EPLGVMPTHMGQGRY | 491 | Q6ZV50 | |
| MNMLAGPQPYGGSKR | 81 | Q9C0C2 | |
| KSYPMEPMVNGGGYP | 546 | Q9HBL0 | |
| GEMYPHGLEMERIPG | 256 | Q5T1R4 | |
| GPIYPGHGMMFVRND | 11 | Q9UHA3 | |
| YPKPVMPNMIFIGGI | 261 | O60656 | |
| LLGGETAEMPDMYPP | 566 | P22102 | |
| GQMRLGFSGDMYPRP | 161 | Q15915 | |
| IYPFLMRGGKPMPLL | 101 | P18405 | |
| GLVCYMGTFPELMPP | 11 | A0A0U1RRN3 | |
| LGCVMYTMLLGRPPF | 266 | Q9NYY3 | |
| IPEVLMGMPYGSIPR | 276 | Q8TDI7 | |
| MGMPYGSIPRKTVPR | 281 | Q8TDI7 | |
| FGNVYLFLPSMMPIG | 756 | Q01831 | |
| FMRPGSMGLPRFYPA | 31 | Q14966 | |
| YPKPVMPNMIFIGGI | 261 | Q9HAW7 | |
| YPKPVMPNMIFIGGI | 261 | Q9HAW9 | |
| GRMEGPPPTYSEVMG | 246 | O15165 |